Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Predisposing factors for anti-D immune response in D- patients with chronic liver disease transfused with D+ platelet concentrates.

Burin des Roziers N, Chadebech P, Malard L, Vingert B, Gallon P, Samuel D, Djoudi R, Fillet AM, Pirenne F.

Transfusion. 2019 Apr;59(4):1353-1358. doi: 10.1111/trf.15129. Epub 2019 Jan 3.

PMID:
30604873
2.

Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.

Leibler C, Thiolat A, Hénique C, Samson C, Pilon C, Tamagne M, Pirenne F, Vingert B, Cohen JL, Grimbert P.

J Am Soc Nephrol. 2018 Mar;29(3):1049-1062. doi: 10.1681/ASN.2017060679. Epub 2018 Jan 10.

3.

Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.

Elayeb R, Tamagne M, Pinheiro M, Ripa J, Djoudi R, Bierling P, Pirenne F, Vingert B.

J Immunol. 2017 Dec 1;199(11):3771-3780. doi: 10.4049/jimmunol.1700754. Epub 2017 Oct 20.

4.

Dense red blood cell and oxygen desaturation in sickle-cell disease.

Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FC, Conti M, Rakotoson MG, Habibi A, Khorgami S, Vingert B, Maitre B, Galacteros F, Pirenne F, Bartolucci P.

Am J Hematol. 2016 Oct;91(10):1008-13. doi: 10.1002/ajh.24467. Epub 2016 Aug 4.

5.

Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Elayeb R, Tamagne M, Bierling P, Noizat-Pirenne F, Vingert B.

Haematologica. 2016 Feb;101(2):209-18. doi: 10.3324/haematol.2015.134171. Epub 2015 Oct 1.

6.

Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo.

Kerbrat S, Vingert B, Junier MP, Castellano F, Renault-Mihara F, Dos Reis Tavares S, Surenaud M, Noizat-Pirenne F, Boczkowski J, Guellaën G, Chneiweiss H, Le Gouvello S.

PLoS One. 2015 Aug 28;10(8):e0136885. doi: 10.1371/journal.pone.0136885. eCollection 2015.

7.

Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.

Mahévas M, Michel M, Vingert B, Moroch J, Boutboul D, Audia S, Cagnard N, Ripa J, Menard C, Tarte K, Mégret J, Le Gallou S, Patin P, Thai L, Galicier L, Bonnotte B, Godeau B, Noizat-Pirenne F, Weill JC, Reynaud CA.

J Autoimmun. 2015 Aug;62:22-30. doi: 10.1016/j.jaut.2015.05.006. Epub 2015 Jun 23.

PMID:
26112660
8.

Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.

Vingert B, Tamagne M, Habibi A, Pakdaman S, Ripa J, Elayeb R, Galacteros F, Bierling P, Ansart-Pirenne H, Bartolucci P, Noizat-Pirenne F.

Eur J Immunol. 2015 Jun;45(6):1868-79. doi: 10.1002/eji.201445187. Epub 2015 Apr 15.

9.

The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.

Noizat-Pirenne F, Habibi A, Mekontso-Dessap A, Razazi K, Chadebech P, Mahevas M, Vingert B, Bierling P, Galactéros F, Bartolucci P, Michel M.

Vox Sang. 2015 Apr;108(3):262-7. doi: 10.1111/vox.12217. Epub 2014 Dec 18.

PMID:
25523469
10.

Partial dysfunction of Treg activation in sickle cell disease.

Vingert B, Tamagne M, Desmarets M, Pakdaman S, Elayeb R, Habibi A, Bernaudin F, Galacteros F, Bierling P, Noizat-Pirenne F, Cohen JL.

Am J Hematol. 2014 Mar;89(3):261-6. Erratum in: Am J Hematol. 2015 Jan;90(1):84. Cohen, José [corrected to Cohen, José Laurent].

11.

T-bet is overexpressed in the CD4+ T cells of HIV Controllers: Retracted.

Perez-Patrigeon S, Thèze J, Vingert B.

AIDS. 2013 Mar 12. [Epub ahead of print] No abstract available. Retraction in: AIDS. 2013 Mar 27;27(6):1043.

PMID:
23276805
12.

HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, Jeannin P, Galperin M, Perez-Patrigeon S, Boufassa F, Kwok WW, Lemaître F, Delfraissy JF, Thèze J, Chakrabarti LA.

J Virol. 2012 Oct;86(19):10661-74. doi: 10.1128/JVI.00056-12. Epub 2012 Jul 25.

13.

[Role of CD4 lymphocytes in the efficient immune response of HIV controllers].

Thèze J, Chakrabarti L, Vingert B, Lambotte O, Delfraissy JF.

Bull Acad Natl Med. 2011 Mar;195(3):545-57; discussion 557-9. French.

PMID:
22292304
14.

HIV controllers: a multifactorial phenotype of spontaneous viral suppression.

Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE.

Clin Immunol. 2011 Oct;141(1):15-30. doi: 10.1016/j.clim.2011.07.007. Epub 2011 Aug 4. Review.

15.

HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.

Vingert B, Perez-Patrigeon S, Jeannin P, Lambotte O, Boufassa F, Lemaître F, Kwok WW, Theodorou I, Delfraissy JF, Thèze J, Chakrabarti LA; ANRS EP36 HIV Controllers Study Group.

PLoS Pathog. 2010 Feb 26;6(2):e1000780. doi: 10.1371/journal.ppat.1000780.

16.

HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression.

Perez-Patrigeon S, Vingert B, Lambotte O, Viard JP, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2009 Jun 19;23(10):1197-207. doi: 10.1097/QAD.0b013e32832c4b0a.

PMID:
19455014
17.

Characterization of immune functions in TRAF4-deficient mice.

Cherfils-Vicini J, Vingert B, Varin A, Tartour E, Fridman WH, Sautès-Fridman C, Régnier CH, Cremer I.

Immunology. 2008 Aug;124(4):562-74. doi: 10.1111/j.1365-2567.2008.02810.x. Epub 2008 Feb 18.

18.

Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.

Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle JH, Urrutia A, Scott-Algara D, Boufassa F, Delfraissy JF, Thèze J, Venet A, Chakrabarti LA.

J Virol. 2007 Dec;81(24):13904-15. Epub 2007 Oct 10.

19.

B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity.

Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, Haicheur N, Amessou M, Herbelin A, Langlade-Demoyen P, Fridman WH, Lemonnier F, Johannes L, Tartour E.

J Immunol. 2007 Sep 1;179(5):3371-9.

20.

Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

El Houda Agueznay N, Badoual C, Hans S, Gey A, Vingert B, Peyrard S, Quintin-Colonna F, Ravel P, Bruneval P, Roncelin S, Lelongt B, Bertoglio J, Fridman WH, Brasnu D, Tartour E.

Clin Exp Immunol. 2007 Oct;150(1):114-23. Epub 2007 Aug 3.

21.

The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity.

Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L, Eppolito C, Sapoznikov A, Amessou M, Quintin-Colonna F, Fridman WH, Johannes L, Tartour E.

Eur J Immunol. 2006 May;36(5):1124-35.

22.

[Phenotypic and functional analysis of T lymphocytes in cancer patients].

Badoual C, Vingert B, Agueznay N, Adotevi O, Haicheur N, Molina T, Bruneval P, Fridman WH, Tartour E.

Ann Pathol. 2005 Jun;25(3):211-9. Review. French.

PMID:
16230947
23.

Fluorospot assay: methodological analysis.

Gazagne A, Malkusch W, Vingert B, Fridman WH, Tartour E.

Methods Mol Biol. 2005;302:289-96.

PMID:
15937359
24.

Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.

Godard B, Gazagne A, Gey A, Baptiste M, Vingert B, Pegaz-Fiornet B, Strompf L, Fridman WH, Glotz D, Tartour E.

Hum Immunol. 2004 Nov;65(11):1307-18.

PMID:
15556681
25.
26.
27.

Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy.

Andreoletti M, Loux N, Vons C, Nguyen TH, Lorand I, Mahieu D, Simon L, Di Rico V, Vingert B, Chapman J, Briand P, Schwall R, Hamza J, Capron F, Bargy F, Franco D, Weber A.

Hum Gene Ther. 2001 Jan 20;12(2):169-79.

PMID:
11177554

Supplemental Content

Loading ...
Support Center